Well they had statistically significant results on people who had only had a partial immune response to other treatments using a drug that had minimal side effects.
They also used a pretty specific subset of trial candidates, those that had only had partial immune reconstitution, i’d like to understand this more and whether it would be effective more broadly speaking.
if they use it with candidates that had a better immune reconstitution, would this help a cure?
- Forums
- ASX - By Stock
- BIT
- Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-14
-
- There are more pages in this discussion • 102 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.001(2.63%) |
Mkt cap ! $34.28M |
Open | High | Low | Value | Volume |
3.9¢ | 3.9¢ | 3.9¢ | $4.073K | 104.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 227908 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 186024 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 227908 | 0.038 |
3 | 443512 | 0.037 |
5 | 388512 | 0.036 |
6 | 753214 | 0.035 |
4 | 646000 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 186024 | 2 |
0.041 | 230121 | 4 |
0.042 | 117600 | 1 |
0.043 | 102000 | 1 |
0.044 | 140000 | 1 |
Last trade - 10.25am 03/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online